Search

A team of researchers from Memorial Sloan Kettering Cancer Center (MSK) and Weill-Cornell Medical College have identified, for the first time, a new molecular pathway that is required for acute myeloid leukemia (AML) development. This work could provide a rationale for targeting the RNA methylation program in myeloid leukemia.

… Monday, September 18, 2017 Bottom Line A team of researchers from Memorial Sloan Kettering Cancer Center (MSK) and Weill-Cornell Medical College have identified, for the first time, a new molecular pathway that is required for acute myeloid leukemia (AML) development. This work could provide a rationale

Memorial Sloan Kettering Cancer Center (MSK) announces the following awards and appointments.

… Friday, April 28, 2023 Selwyn Vickers Selwyn Vickers Delivered the American Association for Cancer Research’s Minorities in Cancer Research Jane Cooke Wright Lectureship Selwyn M. Vickers, MD, FACS, President and CEO , was the recipient of the American Association for Cancer Research (AACR) Minorities

Giving a two-drug combination before prostate cancer surgery appears to reduce the chance that some high-risk forms of the disease will come back.

… Monday, May 6, 2019 Summary One of the standard treatments for prostate cancer that has not spread is surgery to remove the prostate . Results from a phase III trial show that for men with high-risk forms of the disease, giving a combination of drugs before surgery can lower the risk of prostate cancer

Learn about "American Symphony," a documentary featuing a love story, a cancer journey, and a campaign to help save people who need bone marrow donations to fight blood cancer.

… Monday, June 10, 2024 Suleika Jaouad seen in hospital bed during stem cell transplant Suleika Jaouad during stem cell transplant at MSK.   Life often imitates art. But in the documentary film American Symphony , life interrupted art instead. As a result, a love story for the ages unfolded on-screen,

Read an interview with Sloan Kettering Institute immunologist Justin Perry.

… Friday, January 1, 2021 Immunologist Justin Perry came to the Sloan Kettering Institute (SKI) in 2019, after completing his graduate studies at Washington University in St. Louis and a postdoctoral fellowship at the University of Virginia. His lab studies cell death and how the body deals with the millions

Memorial Sloan Kettering Cancer Center (MSK) experts presented their latest advances in oncology research at the American Association for Cancer Research (AACR) Annual Meeting 2025, held April 25 to 30 in Chicago.

… Tuesday, April 29, 2025 Memorial Sloan Kettering Cancer Center (MSK) experts presented their latest advances in oncology research at the American Association for Cancer Research (AACR) Annual Meeting 2025, held April 25 to 30 in Chicago.  Highlights included breakthrough findings in mismatch-repair deficient

In an effort to improve patients’ response to immunotherapy, MSK researchers have studied how microorganisms in the gut affect outcomes in people receiving CAR T therapy.

… Monday, March 14, 2022 In an ongoing effort to improve patients’ response to immunotherapy, MSK researchers have studied how microorganisms in the gut affect outcomes in people receiving chimeric antigen receptor (CAR) T therapy for some types of leukemia and lymphoma. With CAR T therapy, a patient’s

Researchers discover how immune cells called macrophages regulate whether fat is stored or burned.

… Thursday, July 8, 2021 All creatures need to carefully manage their diet to stay alive. Food may not always be available, so organisms from insects to humans have developed an innate sense of when to burn energy and when to save it for later. Living things stockpile energy in the form of fat cells called

A multi-institution team co-led by MSK researchers has pinpointed what could be the early genetic origins of breast cancer.

… Wednesday, November 20, 2024 Researchers at the University of British Columbia (UBC), BC Cancer, Harvard Medical School and Memorial Sloan Kettering Cancer Center (MSK) have pinpointed what could be the early genetic origins of breast cancer — cancer-like mutations appearing in the cells of healthy women

New MSK research identifies new cancer-specific targets for T cell receptor immunotherapy approaches; sheds light on a critical process in sexual reproduction; describes how regulatory T cells help prevent intestinal inflammation; and uncovers how the spleen helps natural killer immune cells adapt to new threats.

… Monday, March 3, 2025 New research from Memorial Sloan Kettering Cancer Center (MSK) identifies new cancer-specific targets for T cell receptor immunotherapy approaches; sheds light on a critical process in sexual reproduction; describes how regulatory T cells help prevent intestinal inflammation; and